| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $12.4M | — |
| R&D Expense | $77.8M | +43.7% |
| SG&A Expense | $38.9M | +22.0% |
| Operating Income | -$104.4M | -21.3% |
| Net Income | -$101.1M | -17.8% |
| EPS (Basic) | -$2.60 | -11.1% |
| EPS (Diluted) | -$2.60 | -11.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $113.6M | -21.6% |
| Current Assets | $244.1M | +6.5% |
| Total Assets | $256.1M | +7.2% |
| Current Liabilities | $31.4M | +83.2% |
| Total Liabilities | $71.2M | +237.7% |
| Stockholders' Equity | $184.8M | -15.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$31.9M | +52.4% |
| Capital Expenditures | $4.0M | +230.2% |
| Investing Cash Flow | -$45.9M | +40.0% |
| Financing Cash Flow | $46.4M | +3514.4% |
| Free Cash Flow | -$35.8M | +47.4% |